These results suggested that TM6SF2 rs58542926 could be used to identify individuals at higher susceptibility to chronic liver disease, especially for HCC, cirrhosis, ALD, and NAFLD. This evidence concerns the gene TM6SF2 and metabolic dysfunction-associated steatotic liver disease.